Investors / United States / Broadview Ventures
Broadview Ventures
Venture capital · Boston, MA, United States · North America
Broadview Ventures is a mission-driven investment organization that makes equity investments in companies developing technologies for the diagnosis and treatment of cardiovascular disease and stroke. It was established in 2009 to address the translational gap by providing seed and early-stage funding, and it supports the Leducq Charitable Trust in identifying investments.
Invests inHealthcare & Biotech
In its own wordscardiovascularstrokemedical devicestherapeuticshealthcarelife sciences
Your fit with Broadview Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBroadview Ventures lists 40 checked portfolio companies on its own site and is named in 2 funding rounds, 2 of them as lead. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 70% of its companies are based in United States. It invests most often alongside Hatteras Venture Partners, Viva BioInnovator and BayMed Venture Partners.
Counts come from funding rounds that name Broadview Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Broadview Ventures' whole history. Rounds on record name 2 companies; its own site lists 40. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 1 |
| '25 | 1 | 1 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 77th | 40 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 63th | 5% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 91th | 8 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Hatteras Venture Partners | 3 |
| Viva BioInnovator | 3 |
| BayMed Venture Partners | 2 |
| Champel Capital | 2 |
| Epidarex | 2 |
| GEOC | 2 |
| Laerdal Million Lives Fund | 2 |
| Omega Funds | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers40100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Hatteras Venture Partners
Compare Broadview Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Broadview Ventures| Date | Company | Stage |
|---|---|---|
| 9 Jun 2025 | Series A Led | |
| 10 Sept 2024 | Series B Led |
Round details for Broadview Ventures
Amounts, full round histories and every co-investor in Broadview Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
40 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Acesion Pharma aims to develop more efficacious and safe drugs for the treatment of atrial fibrillation, the most common type of cardiac arrhythmia. | Healthcare & Biotech | Portfolio page | ||
| Adient Medical develops absorbable medical devices, including a vascular filter, to prevent pulmonary embolism. | Healthcare & Biotech | Portfolio page | ||
| Aeromics is a clinical-stage pharmaceutical company developing a therapy for severe, acute ischemic stroke | Healthcare & Biotech | Portfolio page | ||
| Alleviant Medical is currently evaluating interatrial shunt therapy in heart failure patients through clinical trials. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Antag Therapeutics is pioneering a new class of therapies for people living with obesity, diabetes and overweight. | Healthcare & Biotech | Portfolio page | ||
| AtaCor Medical designs novel extravascular defibrillation leads and deployment systems for cardiac rhythm management | Healthcare & Biotech | Portfolio page | ||
| Basking Biosciences is developing a targeted, highly specific, short-acting therapy with a direct-acting reversal agent to treat life-threatening clots | Healthcare & Biotech | Portfolio page | ||
| BioKier is a clinical-stage company developing oral products for the management of lipids and glucose | Healthcare & Biotech | Portfolio page | ||
| Capricor Therapeutics is a biotechnology company offering a new approach on drug development in Duchenne muscular dystrophy and beyond. | Healthcare & Biotech | Portfolio page | ||
| Cardiosense develops a heart failure monitoring solution to noninvasively determine Pulmonary Capillary Wedge Pressure at the point of care. | Healthcare & Biotech | Portfolio page | ||
| Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. | Healthcare & Biotech | Portfolio page | ||
| Corflow develops solutions for detecting and treating microvascular disease, specifically microvascular obstruction in heart attack patients. | Healthcare & Biotech | Sept 2024Series B | Page + round | |
| Croivalve develops a minimally invasive heart valve device called the DUO Adapt System to treat tricuspid regurgitation | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Epirium Bio is a biopharmaceutical company that has identified and established an IP-protected platform of orally bioavailable small molecules to restore tissue homeostasis and improve function in various diseases. | Healthcare & Biotech | Portfolio page | ||
| FineHeart develops innovative solutions for cardiology, including a breakthrough therapy for the treatment of advanced heart failure | Healthcare & Biotech | Portfolio page | ||
| Gila Therapeutics is developing treatments for obesity and cardiometabolic disorders using a biological pathway related to the tongue-brain connection. | Healthcare & Biotech | Portfolio page | ||
| GI Windows Surgical develops a novel approach to create a magnetic anastomosis for less invasive surgery | Healthcare & Biotech | Portfolio page | ||
| Vascular Graft Solutions develops and provides technologies to improve coronary bypass surgery outcomes | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- broadviewventures.org
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 10 Sept 2024
- Companies checked
- 40
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Broadview Ventures' profile as data
Pull Broadview Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/broadviewventures.org
# also
GET /v1/firms/broadviewventures.org/portfolio
GET /v1/firms/broadviewventures.org/coinvestors
GET /v1/firms/broadviewventures.org/news